Apeiron Biologics AG

News from this company

News

Ligand Pharmaceuticals to Acquire Apeiron Biologics for €92 Million

09.07.2024 -

Ligand Pharmaceuticals recently announced that it has entered into a definitive agreement to acquire Apeiron Biologics AG, which holds royalty rights to Qarziba...

Contact

Apeiron Biologics AG

Campus-Vienna-Biocenter 5
A-1030 Wien

+43 86565 77
+43 86565 77 800